Related Experiment Videos
Green tea regulates cell cycle progression in oral leukoplakia
A Khafif1, S P Schantz, M al-Rawi
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Head & Neck
|August 14, 1998
Summary
(-)-epigallocatechin-3-gallate (EGCG) from green tea inhibits oral cancer cell growth. Cancerous cells showed less response to EGCG, indicating potential limitations for chemoprevention strategies.
Area of Science:
- Oncology
- Chemoprevention
- Molecular Biology
Background:
- Developed an in vitro multi-stage carcinogenesis model for oral cancer.
- Investigated chemopreventive strategies using this model.
- Focused on EGCG, a major green tea constituent, for its mechanisms of action.
Purpose of the Study:
- To examine the chemopreventive effects of EGCG on oral cancer.
- To understand the mechanisms of action of EGCG in oral carcinogenesis.
- To evaluate EGCG's efficacy across different stages of oral epithelial development.
Main Methods:
- Utilized an in vitro multi-stage oral cancer model.
- Assessed EGCG effects using growth assays and cell cycle analysis.
- Examined retinoblastoma protein (pRB) levels via western blots.
Main Results:
- EGCG inhibited cell growth in all tested oral cell types.
- Growth inhibition efficacy decreased as cells progressed from normal to cancerous states.
- EGCG induced a G1 cell cycle block, increasing underphosphorylated pRB; inhibition was reversible without resistance development.
Conclusions:
- The multistage carcinogenesis model effectively defined EGCG's chemopreventive value.
- Oral cancerous epithelium demonstrated reduced responsiveness to EGCG compared to normal or dysplastic tissues.
- Further research is needed to define the mechanisms underlying the differential response of cancerous tissues to EGCG.